ACAD Q1 2017 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+382050.0% YoY

Gross Profit

$12M80.8% margin

Operating Income

-$89M-581.0% margin

Net Income

-$88M-574.7% margin

EPS (Diluted)

$-0.72

QoQ Revenue Growth

+27.8%

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$71M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$503M

Total Liabilities

$45M

Stockholders' Equity

$458M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$4,000	+382050.0%
Gross Profit	$12M	-$23M	+154.2%
Operating Income	-$89M	-$50M	-76.7%
Net Income	-$88M	-$50M	-76.5%